Literature DB >> 1328304

Thrombin receptor expression in normal and atherosclerotic human arteries.

N A Nelken1, S J Soifer, J O'Keefe, T K Vu, I F Charo, S R Coughlin.   

Abstract

Thrombin is a multifunctional serine protease generated at sites of vascular injury. A host of thrombin actions on vascular endothelial cells, smooth muscle cells, and macrophages has been defined in cell culture systems, but the in vivo significance of these activities is unknown. We have defined the expression of the recently identified receptor for thrombin in human arteries by both in situ hybridization and immunohistochemistry. In normal-appearing arteries, thrombin receptor was expressed almost exclusively in the endothelial layer. By contrast, in human atheroma, the receptor was widely expressed, both in regions rich in macrophages and in regions rich in vascular smooth muscle cells and mesenchymal-appearing intimal cells of unknown origin. Thrombin receptor was expressed by human vascular endothelial cells and smooth muscle cells in culture and by macrophages obtained by bronchioalveolar lavage, thus demonstrating that all three cell types are indeed capable of expressing the thrombin receptor. These results establish thrombin receptor activation as a candidate for contributing to sclerotic and inflammatory processes in the human vasculature, such as those that occur in atherosclerosis and restenosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328304      PMCID: PMC443210          DOI: 10.1172/JCI116031

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.

Authors:  D T Hung; T K Vu; V I Wheaton; I F Charo; N A Nelken; N Esmon; C T Esmon; S R Coughlin
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 2.  Characterization of a functional thrombin receptor. Issues and opportunities.

Authors:  S R Coughlin; T K Vu; D T Hung; V I Wheaton
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.

Authors:  D T Hung; T K Vu; V I Wheaton; K Ishii; S R Coughlin
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

5.  "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides.

Authors:  R S Huang; A Sorisky; W R Church; E R Simons; S E Rittenhouse
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

6.  Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187.

Authors:  B B Weksler; C W Ley; E A Jaffe
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

8.  Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis.

Authors:  V Vouret-Craviari; E Van Obberghen-Schilling; U B Rasmussen; A Pavirani; J P Lecocq; J Pouysségur
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

9.  Mitogenic activity of blood components. I. Thrombin and prothrombin.

Authors:  L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.

Authors:  D T Hung; T H Vu; N A Nelken; S R Coughlin
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

View more
  48 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells.

Authors:  Hsin-Hua Chou; Hiromichi Yumoto; Michael Davey; Yusuke Takahashi; Takanari Miyamoto; Frank C Gibson; Caroline A Genco
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells.

Authors:  Y Wu; J Ruef; G N Rao; C Patterson; M S Runge
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 4.  G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease.

Authors:  Till F Althoff; Stefan Offermanns
Journal:  J Mol Med (Berl)       Date:  2015-06-14       Impact factor: 4.599

5.  Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.

Authors:  Leila M Sevigny; Karyn M Austin; Ping Zhang; Shogo Kasuda; Georgios Koukos; Sheida Sharifi; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

6.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

7.  Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development.

Authors:  S J Soifer; K G Peters; J O'Keefe; S R Coughlin
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

9.  Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase.

Authors:  Jong-Sup Bae; Yong-Ung Kim; Moon-Ki Park; Alireza R Rezaie
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

10.  Molecular mapping of the heparin-binding exosite of thrombin.

Authors:  J P Sheehan; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.